Why are you looking at Adaptive Biotechnologies?
Email me when a Adaptive Biotechnologies recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · MEDICAL LABORATORIES · TESTING LABORATORIES AND SERVICES
Work mix: 58% prime · 42% sub · primary NAICS 621511 / PSC Q301 REFERENCE LABORATORY TESTING
Where they win
3 agenciesMostly sole-source · 110%
110% of Adaptive Biotechnologies’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
3 buyersRecompete exposure
LowLargely sole-source — these contracts typically renew with Adaptive Biotechnologies rather than being openly recompeted.
Adaptive Biotechnologies has an estimated $244K in contracts returning to market over the next 24 months. 1 within 6 months ($244K).
Adaptive Biotechnologies teams with
1Partners from federal subaward / teaming records (public).
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Adaptive Biotechnologies hold?
Adaptive Biotechnologies (UEI DMW5BNQ331K9) shows $843K across 24 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Adaptive Biotechnologies have?
Adaptive Biotechnologies shows $843K across 24 award actions. SCOUT tracks 1 incumbent recompetes ($244K) returning to market in the next 24 months.
Which agencies does Adaptive Biotechnologies work with?
Adaptive Biotechnologies’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (47%), Department of Defense (DOD) (44%), Department of Veterans Affairs (VA) (9%).
What is the UEI for Adaptive Biotechnologies?
The Unique Entity ID (UEI) for Adaptive Biotechnologies is DMW5BNQ331K9.
Does Adaptive Biotechnologies have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Adaptive Biotechnologies — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.